Objective Nosebleed, also known as epistaxis, is a common problem that occurs at some
point in at least 60% of people in the United States. While the majority of nosebleeds are …

Immune thrombocytopenia (ITP) is characterized by a platelet count less than 100× 10^ 9/L
without anemia or leukopenia. Patients with ITP may be asymptomatic, or they may have …

Introduction Over the last decade, tranexamic acid (TXA) has been incorporated into
treatment algorithms for a multitude of emergent conditions and the evidence surrounding its …

Introduction Epistaxis is a very common presentation in the emergency department (ED),
accounting for approximately 1 in 200 ED visits in the United States. Currently, standard …

Study objective The primary objective of this study is to compare the effectiveness of 3
treatment protocols to stop anterior epistaxis: classic compression, nasal packing, and local …

Study objective To determine the effectiveness of intranasal topical application of tranexamic
acid in reducing the need for anterior nasal packing and determine the number of episodes …

Study objective Epistaxis is a common emergency department (ED) presentation and, if
simple first aid measures fail, can lead to a need for anterior nasal packing. Tranexamic acid …

Epistaxis means bleeding from nostrils, nasal cavity or nasopharynx. To summarize the
available epistaxis treatment options. Methods: 61 articles published in the last 20 years …

Abstract Purpose of Review The purpose of current systematic review and meta-analysis is
to determine the efficacy and safety of the administration of tranexamic acid in patients …

Objective Tranexamic acid (TXA) is an antifibrinolytic agent used to control bleeding in
different circumstances. We conducted a randomized controlled trial to assess the efficacy …